All of the infection control company’s safety and standard syringe products are available to Health Affiliated Services members including the flagship product, InviroSNAP with InviroSTRIPE Safety Syringe, featuring
Under the terms of the agreement, based on compounds discovered by Exelgen, the company’s partner will receive an option to license the compounds and collaborate in specific programs.
The data showed that Debio 0614 is able to significantly reduce pulmonary congestion in patients admitted with worsening heart failure and left ventricular dysfunction. The results of the
Cell Kinetics an indirect majority-owned subsidiary of Medis Technologies, is developing and will market a series of products, based on its Cell Carrier technology, under the CKChip trade
CG Therapeutics is commercializing CG201, a proprietary vaccine that produces antibodies that neutralize hCG, a powerful hormone produced by tumor cell to speed their growth. The new joint
This drug is designed to reduce restenosis or re-blocking of arteries after surgery to clear blockages, commonly involving insertion of arterial stents. The study is being conducted in
The Samsill ring binders feature the Agion technology to inhibit the growth of bacteria, mold, mildew, and fungi on surfaces and maintains antimicrobial efficacy for the life of
The studies are designed to evaluate the potential of the Hemopurifier to treat West Nile virus (WNV), and to further demonstrate the broad-spectrum effectiveness of the Hemopurifier to
This acquisition marking Fujirebio’s entry into the controls and calibrators manufacturing business will enable the company to further strengthen its position in the evolving in vitro diagnostics industry.
Orphan-drug designation for resveratrol in Melas (Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) syndrome provides company with seven years of marketing exclusivity upon receipt of FDA approval.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.